Quick Takeaways
- INTEGRATED CORE STRATEGIES (US) LLC filed SCHEDULE 13G/A for Karyopharm Therapeutics Inc. Common Stock, par value $0.0001 per share (KPTI).
- Disclosed ownership: 2.3%.
- Date of event: 31 Mar 2026.
INTEGRATED CORE STRATEGIES (US) LLC - 31 Mar 2026 SCHEDULE 13G/A Report for Karyopharm Therapeutics Inc. Common Stock, par value $0.0001 per share (KPTI)
- Filing Manager
- INTEGRATED CORE STRATEGIES (US) LLC
- Reporting Manager
- Millennium Management LLC
- Symbol
- KPTI
- Shares outstanding
- 22,242,217 shares
- Disclosed Ownership
- 511,571 shares
- Ownership
- 2.3%
- Form type
- SCHEDULE 13G/A
- Filing time
- 13 Apr 2026, 17:28:39 UTC
- Date of event
- 31 Mar 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"INTEGRATED CORE STRATEGIES (US) LLC disclosed 2.3% ownership in Karyopharm Therapeutics Inc. Common Stock, par value $0.0001 per share (KPTI) on 31 Mar 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 13 Apr 2026, 17:28.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Integrated Core Strategies (US) LLC | 1.9% | 423,982 | 0 | 423,982 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Millennium Management LLC | 2.3% | 511,571 | 0 | 511,571 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Millennium Group Management LLC | 2.3% | 511,571 | 0 | 511,571 | /s/ Gil Raviv | Gil Raviv, Global General Counsel | |
| Israel A. Englander | 2.3% | 511,571 | 0 | 511,571 | /s/ Israel A. Englander | Israel A. Englander |